Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds

BackgroundHemorrhagic transformation is one of the most serious complications in intravenous thrombolysis. Studies show that the existence of more than 10 cerebral microbleeds is strongly associated with hemorrhagic transformation. The current study attempts to develop and validate a clinical predic...

Full description

Bibliographic Details
Main Authors: Yifan Li, Haifeng Gao, Dongsen Zhang, Xuan Gao, Lin Lu, Chunqin Liu, Qian Li, Chunzhi Miao, Hongying Ma, Yongqiu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.833952/full
_version_ 1818394157228490752
author Yifan Li
Haifeng Gao
Dongsen Zhang
Xuan Gao
Lin Lu
Chunqin Liu
Qian Li
Chunzhi Miao
Hongying Ma
Yongqiu Li
author_facet Yifan Li
Haifeng Gao
Dongsen Zhang
Xuan Gao
Lin Lu
Chunqin Liu
Qian Li
Chunzhi Miao
Hongying Ma
Yongqiu Li
author_sort Yifan Li
collection DOAJ
description BackgroundHemorrhagic transformation is one of the most serious complications in intravenous thrombolysis. Studies show that the existence of more than 10 cerebral microbleeds is strongly associated with hemorrhagic transformation. The current study attempts to develop and validate a clinical prediction model of more than 10 cerebral microbleeds.MethodsWe reviewed the computed tomography markers of cerebral small vessel diseases and the basic clinical information of acute ischemic stroke patients who were investigated using susceptibility weighted imaging from 2018 to 2021. A clinical prediction model of more than 10 cerebral microbleeds was established. Discrimination, calibration, and the net benefit of the model were assessed. Finally, a validation was conducted to evaluate the accuracy and stability of the model.ResultsThe multivariate logistic regression model showed hypertension, and some computed tomography markers (leukoaraiosis, lacunar infarctions, brain atrophy) were independent risk factors of more than 10 cerebral microbleeds. These risk factors were used for establishing the clinical prediction model. The area under the receiver operating characteristic curve (AUC) was 0.894 (95% CI: 0.870–0.919); Hosmer–Lemeshow chi-squared test yielded χ2 = 3.946 (P = 0.862). The clinical decision cure of the model was higher than the two extreme lines. The simplified score of the model ranged from 0 to 12. The model in the internal and external validation cohort also had good discrimination (AUC 0.902, 95% CI: 0.868–0.937; AUC 0.914, 95% CI: 0.882–0.945) and calibration (P = 0.157, 0.247), and patients gained a net benefit from the model.ConclusionsWe developed and validated a simple scoring tool for acute ischemic stroke patients with more than 10 cerebral microbleeds; this tool may be beneficial for paradigm decision regarding intravenous recombinant tissue plasminogen activator therapy of acute ischemic stroke.
first_indexed 2024-12-14T05:56:44Z
format Article
id doaj.art-e97c95fadf4b46c0aba56fbf3012120b
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-14T05:56:44Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-e97c95fadf4b46c0aba56fbf3012120b2022-12-21T23:14:33ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-04-011310.3389/fneur.2022.833952833952Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral MicrobleedsYifan Li0Haifeng Gao1Dongsen Zhang2Xuan Gao3Lin Lu4Chunqin Liu5Qian Li6Chunzhi Miao7Hongying Ma8Yongqiu Li9Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaDepartment of Neurology, Tangshan Gongren Hospital, Tangshan, ChinaBackgroundHemorrhagic transformation is one of the most serious complications in intravenous thrombolysis. Studies show that the existence of more than 10 cerebral microbleeds is strongly associated with hemorrhagic transformation. The current study attempts to develop and validate a clinical prediction model of more than 10 cerebral microbleeds.MethodsWe reviewed the computed tomography markers of cerebral small vessel diseases and the basic clinical information of acute ischemic stroke patients who were investigated using susceptibility weighted imaging from 2018 to 2021. A clinical prediction model of more than 10 cerebral microbleeds was established. Discrimination, calibration, and the net benefit of the model were assessed. Finally, a validation was conducted to evaluate the accuracy and stability of the model.ResultsThe multivariate logistic regression model showed hypertension, and some computed tomography markers (leukoaraiosis, lacunar infarctions, brain atrophy) were independent risk factors of more than 10 cerebral microbleeds. These risk factors were used for establishing the clinical prediction model. The area under the receiver operating characteristic curve (AUC) was 0.894 (95% CI: 0.870–0.919); Hosmer–Lemeshow chi-squared test yielded χ2 = 3.946 (P = 0.862). The clinical decision cure of the model was higher than the two extreme lines. The simplified score of the model ranged from 0 to 12. The model in the internal and external validation cohort also had good discrimination (AUC 0.902, 95% CI: 0.868–0.937; AUC 0.914, 95% CI: 0.882–0.945) and calibration (P = 0.157, 0.247), and patients gained a net benefit from the model.ConclusionsWe developed and validated a simple scoring tool for acute ischemic stroke patients with more than 10 cerebral microbleeds; this tool may be beneficial for paradigm decision regarding intravenous recombinant tissue plasminogen activator therapy of acute ischemic stroke.https://www.frontiersin.org/articles/10.3389/fneur.2022.833952/fullcerebral microbleedsprediction modelcerebral small vessel diseaseintravenous thrombolysishemorrhagic transformation
spellingShingle Yifan Li
Haifeng Gao
Dongsen Zhang
Xuan Gao
Lin Lu
Chunqin Liu
Qian Li
Chunzhi Miao
Hongying Ma
Yongqiu Li
Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds
Frontiers in Neurology
cerebral microbleeds
prediction model
cerebral small vessel disease
intravenous thrombolysis
hemorrhagic transformation
title Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds
title_full Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds
title_fullStr Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds
title_full_unstemmed Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds
title_short Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds
title_sort clinical prediction model for screening acute ischemic stroke patients with more than 10 cerebral microbleeds
topic cerebral microbleeds
prediction model
cerebral small vessel disease
intravenous thrombolysis
hemorrhagic transformation
url https://www.frontiersin.org/articles/10.3389/fneur.2022.833952/full
work_keys_str_mv AT yifanli clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT haifenggao clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT dongsenzhang clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT xuangao clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT linlu clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT chunqinliu clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT qianli clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT chunzhimiao clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT hongyingma clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds
AT yongqiuli clinicalpredictionmodelforscreeningacuteischemicstrokepatientswithmorethan10cerebralmicrobleeds